0102030405
Baricitinib CAS No 1187594-09-7 Pharmaceutical Intermediates
02
introduce
7 Jan 2019
Baricitinib is a high-quality pharmaceutical product designed to meet the stringent requirements of the pharmaceutical industry. As an integrated production and trading factory, we are proud to offer this versatile solution, which is a white or off-white crystalline powder, odorless and tasteless, with good solubility in DMSO and DMF, and under storage conditions Has excellent stability.
02
Main selling points
7 Jan 2019
1. High-quality ingredients: Baricitinib is a white or off-white crystalline powder, ensuring high purity and quality for pharmaceutical applications. Its odorless and tasteless properties make it suitable for use in a variety of formulations, enhancing its versatility in pharmaceutical applications.
2. Excellent solubility: Baricitinib has good solubility in DMSO (up to 30mg/ml) or DMF (up to 50mg/ml), making it easy to integrate into various pharmaceutical processes. This feature enhances its compatibility with different formulations, providing flexibility and convenience to pharmaceutical companies.
3. Long-term stability: Baricitinib can maintain stability for up to 2 years under storage conditions of -20°C, providing pharmaceutical companies with reliable and long-lasting product guarantees. Additionally, its DMSO or DMF solutions can be stored at -20°C for up to 3 months, ensuring extended availability and convenience.
- Quality Assurance: Our factory adheres to strict quality control measures to ensure the purity and stability of baricitinib. We prioritize our customers' safety and satisfaction, making quality assurance a top priority at every stage of production.
- Integrated production and trading: As an integrated factory, we oversee the entire production and trading process of baricitinib to ensure it meets the highest quality and purity standards. Our commitment to excellence and reliability makes us a trusted partner for pharmaceutical companies seeking quality ingredients.
- Technical expertise: Our team of experts has deep technical knowledge and experience in pharmaceutical manufacturing, ensuring that baricitinib meets industry-specific requirements. We are committed to providing technical support and guidance to our customers and fostering collaborative and productive partnerships.
Etoricoxib intermediates play a vital role in the pharmaceutical industry and are key components in the synthesis of etoricoxib. This NSAID is widely used to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Pharmaceutical manufacturers rely on our high-quality intermediates to ensure the effectiveness, safety and consistency of final etoricoxib formulations, thereby improving the overall quality of patient care.
In summary, etoricoxib intermediates are an important part of the pharmaceutical industry with exceptional quality, reliability and versatility. With our comprehensive manufacturing and trading capabilities, we are committed to meeting the diverse needs of pharmaceutical manufacturers by providing quality intermediates that meet the highest standards of excellence.
Under the subheading Description, product details for baricitinib include its chemical properties, recommended usage, storage conditions, and any other relevant information. This comprehensive overview ensures pharmaceutical companies have all the necessary details to make informed decisions about incorporating baricitinib into their products.
In summary, baricitinib is a high-quality pharmaceutical solution tailored to the diverse needs of the industry. With its excellent solubility, stability and purity, it provides pharmaceutical companies with a reliable and adaptable ingredient for their formulations. As an integrated facility, we are committed to maintaining the highest quality and purity standards, making Baricitinib a trusted choice for pharmaceutical companies seeking premium product ingredients.